Peptic Ulcer Disease (PUD), Diagnosis, and Current Medication-Based Management Options: Schematic Overview

Srivastav, Yash and Kumar, Vijay and Srivastava, Yashi and Kumar, Madhaw (2023) Peptic Ulcer Disease (PUD), Diagnosis, and Current Medication-Based Management Options: Schematic Overview. Journal of Advances in Medical and Pharmaceutical Sciences, 25 (11). pp. 14-27. ISSN 2394-1111

[thumbnail of Srivastav25112023JAMPS109508.pdf] Text
Srivastav25112023JAMPS109508.pdf - Published Version

Download (345kB)

Abstract

A common condition in the world, Peptic Ulcer condition is sometimes referred to as stomach ulcers or peptic ulcers. PUD is caused by a defect in the mucosa of the stomach or duodenum that extends beyond the muscularis mucosa. PUD is the consequence of an imbalance between the aggressive and defensive elements impacting the mucosa, which occurs after gastric mucosal lesions. Peptic ulcer disease (PUD) is a widespread ailment affecting 5–10% of the world's population, with notable racial and regional variations. As a result of an imbalance between the aggressive and defensive elements impacting the mucosa, comes gastric mucosal injuries. The word "peptic" comes from the hormone pepsin, which is essential in causing mucosal breakdown. The most common cause of upper gastrointestinal bleeding in the Western world is bleeding from peptic ulcers (PUs). High rates of morbidity, mortality, and medical costs are linked to it. This review article covers the pathophysiology, aetiology, medical therapy, diagnosis, symptoms, and signs of Peptic Ulcer Disease (PUD).

Item Type: Article
Subjects: GO for STM > Medical Science
Depositing User: Unnamed user with email support@goforstm.com
Date Deposited: 04 Dec 2023 04:33
Last Modified: 04 Dec 2023 04:33
URI: http://archive.article4submit.com/id/eprint/2399

Actions (login required)

View Item
View Item